Target intelligence / Profile preview

Zic family member 1 (ZIC1)

Target
ZIC1
Molecular classification
Transcription factor, Zinc finger protein, C2H2-type zinc finger protein
01

Overview

Zic family member 1 (ZIC1) is a C2H2-type zinc finger transcription factor that plays a critical role in neural development, cranial morphogenesis, and organogenesis by regulating the proliferation, differentiation, and regional patterning of neural progenitors[1][2][3][4]. ZIC1 is highly conserved among vertebrates, functions in DNA binding and protein-protein interactions, and acts primarily as a developmental regulator. Loss-of-function or mutation of ZIC1 is associated with congenital disorders such as Dandy–Walker syndrome and craniosynostosis. In cancer, ZIC1 typically functions as a tumor suppressor by inhibiting cell proliferation and promoting apoptosis via regulation of key signaling pathways (MAPK, PI3K/Akt, Wnt/β-catenin), although it may promote oncogenesis in certain mesenchymal tumors. Its function is tightly controlled by both transcriptional and post-transcriptional mechanisms, including mRNA G-quadruplex-mediated translation regulation[1][2][3].

Other names
Zinc finger protein ZIC 1Zinc finger protein 201ZNF201Zinc finger protein of the cerebellum 1BAIDCSCRS6Zic family member 1 (odd-paired homolog, Drosophila)
02

Biological functions

Neural developmentCranial morphogenesisTranscriptional regulationCell proliferationCell differentiationRegulation of regional patterningOsteogenic differentiationInhibition of adipogenic commitment
03

Disease associations

Cancer (tumor suppressor functions in gastrointestinal, ovarian, mesothelioma, glioma, liposarcoma—context-dependent)Neurological disorders (Dandy–Walker malformation, craniosynostosis, cerebellar hypoplasia)Bone disease (osteogenic/adipogenic imbalance)Other congenital malformations
04

Safety considerations

Aberrant expression linked to congenital brain malformations and craniosynostosisAltered dosage or mutations can cause severe developmental defectsDual (oncogenic/suppressor) roles in tumors may complicate therapeutic strategies
05

Biomarkers

Epigenetic status of the ZIC1 promoter (hypermethylation as biomarker in some cancers)

Beyond the preview

Go deeper on Zic family member 1 (ZIC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zic family member 1 (ZIC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call